Status:
UNKNOWN
Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma
Lead Sponsor:
The National Center of Oncology, Azerbaijan
Collaborating Sponsors:
SOFIE INC
Conditions:
Breast Neoplasms
Positron Emission Tomography
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
The aim of this study is to compare the diagnostic performance of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in primary and metastatic lesions of breast cancer and to reveal the best diagnostic imaging ti...
Detailed Description
Participants with breast carcinoma will undergo contemporaneous 18F-FDG and 68Ga-FAPI PET/CT. Tumor uptake will be quantified by the maximum standard uptake value (SUVmax). The sensitivity, specificit...
Eligibility Criteria
Inclusion
- adult participants (aged 18 years or order);
- participants with newly diagnosed breast carcinoma;
- pathology confirmed by lesion tru-cut biopsy;
- participants who were able to provide informed consent.
Exclusion
- participants with non-malignant lesions;
- participants with pregnancy;
- the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Key Trial Info
Start Date :
February 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05339113
Start Date
February 4 2021
End Date
December 1 2022
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Centre of Oncology
Baku, Azerbaijan, AZ1011